Compare Yamazen Corp. with Similar Stocks
Dashboard
1
High Management Efficiency with a high ROE of 7.97%
2
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 44.19
3
Poor long term growth as Net Sales has grown by an annual rate of 4.49% and Operating profit at 2.20% over the last 5 years
4
Positive results in Mar 26
5
With ROE of 6.97%, it has a very attractive valuation with a 1.05 Price to Book Value
6
Underperformed the market in the last 1 year
Stock DNA
Trading & Distributors
JPY 159,827 Million (Small Cap)
15.00
NA
0.00%
-0.47
6.97%
1.20
Revenue and Profits:
Net Sales:
143,430 Million
(Quarterly Results - Mar 2026)
Net Profit:
2,819 Million
Total Returns (Price + Dividend) 
Company does not have enough history
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
4.49%
EBIT Growth (5y)
2.20%
EBIT to Interest (avg)
44.19
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.51
Sales to Capital Employed (avg)
3.63
Tax Ratio
33.98%
Dividend Payout Ratio
57.38%
Pledged Shares
0
Institutional Holding
0.15%
ROCE (avg)
28.60%
ROE (avg)
7.97%
Valuation key factors
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
1.04
EV to EBIT
6.34
EV to EBITDA
4.48
EV to Capital Employed
1.09
EV to Sales
0.14
PEG Ratio
0.58
Dividend Yield
NA
ROCE (Latest)
17.13%
ROE (Latest)
6.97%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Bullish
Bullish
OBV
Bullish
Bullish
Shareholding Snapshot : Sep 2011
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.15%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
143,430.00
138,611.00
3.48%
Operating Profit (PBDIT) excl Other Income
5,035.00
4,604.00
9.36%
Interest
59.00
51.00
15.69%
Exceptional Items
-41.00
0.00
Consolidate Net Profit
2,819.00
2,515.00
12.09%
Operating Profit Margin (Excl OI)
24.80%
24.30%
0.05%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is 3.48% vs 3.67% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 12.09% vs 3.41% in Dec 2025
Annual Results Snapshot (Consolidated) - Mar'26
Mar'26
Mar'25
Change(%)
Net Sales
541,885.00
516,126.00
4.99%
Operating Profit (PBDIT) excl Other Income
17,225.00
14,345.00
20.08%
Interest
204.00
208.00
-1.92%
Exceptional Items
-41.00
-224.00
81.70%
Consolidate Net Profit
9,631.00
8,091.00
19.03%
Operating Profit Margin (Excl OI)
22.20%
18.50%
0.37%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2026 is 4.99% vs 1.83% in Mar 2025
Consolidated Net Profit
YoY Growth in year ended Mar 2026 is 19.03% vs 21.76% in Mar 2025
About Yamazen Corp. 
Yamazen Corp.
Trading & Distributors
No Details Available.
Company Coordinates 
No Company Details Available






